PubMed Randomized trialRetatrutide evidence2023 Triple-Hormone-Receptor Agonist Retatrutide for Obesity, A Phase 2 Trial Primary human trial source for retatrutide obesity efficacy and safety discussions
PLoS ONE 6 , e19831 (2011)
[nice.org.uk] About This Article Medically Reviewed Evidence-Based Sources Updated Regularly Clinically Verified This article was written by THE BALANCEs clinical content team and reviewed by a licensed medical or mental health professional (such as an MD, psychiatrist, clinical psychologist, or equivalent)
Covalent crosslinks, single- and double-strand breaks, and disturbances in redox signaling can emerge from the oxidation and molecular damage that this causes to biological components such as lipids, proteins, and DNA (8, 138)
Have whiter, glowing and acne-free skin guaranteed